13F

NATR NATURES SUNSHINE PRODS INC

2026Q1 · CUSIP 639027101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
152
Δ holders QoQ
+7
Breadth percentile
Top 37%
Whale holders
82
Δ whales
+3
Inst. holding value
$363M
New positions
32
Closed positions
25
Price momentum (1Q)
-16.6%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ-3 · h=53 2018Q2: Δ+2 · h=55 2018Q3: Δ+1 · h=56 2018Q4: Δ+1 · h=57 2019Q1: Δ-5 · h=52 2019Q2: Δ+4 · h=56 2019Q3: Δ+4 · h=60 2019Q4: Δ-1 · h=59 2020Q1: Δ+0 · h=59 2020Q2: Δ+7 · h=66 2020Q3: Δ+4 · h=70 2020Q4: Δ-3 · h=67 2021Q1: Δ+12 · h=79 2021Q2: Δ+0 · h=79 2021Q3: Δ+2 · h=81 2021Q4: Δ+15 · h=96 2022Q1: Δ-1 · h=95 2022Q2: Δ-11 · h=84 2022Q3: Δ+0 · h=84 2022Q4: Δ-1 · h=83 2023Q1: Δ-2 · h=81 2023Q2: Δ+1 · h=82 2023Q3: Δ+10 · h=92 2023Q4: Δ+14 · h=106 2024Q1: Δ+2 · h=108 2024Q2: Δ-8 · h=100 2024Q3: Δ-9 · h=91 2024Q4: Δ+3 · h=94 2025Q1: Δ+1 · h=95 2025Q2: Δ+24 · h=119 2025Q3: Δ+5 · h=124 2025Q4: Δ+21 · h=145 2026Q1: Δ+7 · h=152 2018Q1: holders=53 2018Q2: holders=55 2018Q3: holders=56 2018Q4: holders=57 2019Q1: holders=52 2019Q2: holders=56 2019Q3: holders=60 2019Q4: holders=59 2020Q1: holders=59 2020Q2: holders=66 2020Q3: holders=70 2020Q4: holders=67 2021Q1: holders=79 2021Q2: holders=79 2021Q3: holders=81 2021Q4: holders=96 2022Q1: holders=95 2022Q2: holders=84 2022Q3: holders=84 2022Q4: holders=83 2023Q1: holders=81 2023Q2: holders=82 2023Q3: holders=92 2023Q4: holders=106 2024Q1: holders=108 2024Q2: holders=100 2024Q3: holders=91 2024Q4: holders=94 2025Q1: holders=95 2025Q2: holders=119 2025Q3: holders=124 2025Q4: holders=145 2026Q1: holders=152 -24 -12 +0 +12 +24 46103160 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 13% +28.5% +60.4%
2023Q3 Top 18% +3.5% -12.4%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
19.1
EPS (TTM)
$1.10
EPS YoY
+107.5%
Revenue (TTM)
$0.5B
Revenue YoY
+7.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $104M 2022-09-30: $105M 2022-12-31: $103M 2023-03-31: $109M 2023-06-30: $117M 2023-09-30: $111M 2023-12-31: $109M 2024-03-31: $111M 2024-06-30: $111M 2024-09-30: $115M 2024-12-31: $118M 2025-03-31: $113M 2025-06-30: $115M 2025-09-30: $128M 2025-12-31: $124M 2026-03-31: $123M 2022-06-30: EPS 0.03 2022-09-30: EPS 0.00 2022-12-31: EPS 0.10 2023-03-31: EPS 0.04 2023-06-30: EPS 0.12 2023-09-30: EPS 0.15 2023-12-31: EPS 0.46 2024-03-31: EPS 0.12 2024-06-30: EPS 0.07 2024-09-30: EPS 0.23 2024-12-31: EPS -0.02 2025-03-31: EPS 0.25 2025-06-30: EPS 0.28 2025-09-30: EPS 0.30 2025-12-31: EPS 0.23 2026-03-31: EPS 0.29 0M 64M 128M $M -0.02 0.24 0.51 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 25 2023-03-31: PE 66.22023-06-30: PE 61.92023-09-30: PE 422023-12-31: PE 23.52024-03-31: PE 18.42024-06-30: PE 16.42024-09-30: PE 18.22024-12-31: PE 36.32025-03-31: PE 28.12025-06-30: PE 22.42025-09-30: PE 26.12025-12-31: PE 25.42026-03-31: PE 20.2 15 42 70 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)